PAX8 in the Junction Between Development and Tumorigenesis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jul 9

PMID 35806410

Authors

Reli Rachel Kakun

Zohar Melamed

Ruth Perets

Affiliations

Soon will be listed here.

Abstract

Normal processes of embryonic development and abnormal transformation to cancer have many parallels, and in fact many aberrant cancer cell capabilities are embryonic traits restored in a distorted, unorganized way. Some of these capabilities are cell autonomous, such as proliferation and resisting apoptosis, while others involve a complex interplay with other cells that drives significant changes in neighboring cells. The correlation between embryonic development and cancer is driven by shared proteins. Some embryonic proteins disappear after embryogenesis in adult differentiated cells and are restored in cancer, while others are retained in adult cells, acquiring new functions upon transformation to cancer. Many embryonic factors embraced by cancer cells are transcription factors; some are master regulators that play a major role in determining cell fate. The paired box (PAX) domain family of developmental transcription factors includes nine members involved in differentiation of various organs. All paired box domain proteins are involved in different cancer types carrying pro-tumorigenic or anti-tumorigenic roles. This review focuses on PAX8, a master regulator of transcription in embryonic development of the thyroid, kidney, and male and female genital tracts. We detail the role of PAX8 in each of these organ systems, describe its role during development and in the adult if known, and highlight its pro-tumorigenic role in cancers that emerge from PAX8 expressing organs.

Citing Articles

Current advances in understanding endometrial epithelial cell biology and therapeutic applications for intrauterine adhesion.

Wang J, Zhan H, Wang Y, Zhao L, Huang Y, Wu R Stem Cell Res Ther. 2024; 15(1):379.

PMID: 39456113 PMC: 11515228. DOI: 10.1186/s13287-024-03989-6.

METTL3 regulates thyroid cancer differentiation and chemosensitivity by modulating PAX8.

Kang N, Zhao Z, Wang Z, Ning J, Wang H, Zhang W Int J Biol Sci. 2024; 20(9):3426-3441.

PMID: 38993572 PMC: 11234206. DOI: 10.7150/ijbs.84797.

The Role of the PAX Genes in Renal Cell Carcinoma.

Li L, Hossain S, Eccles M Int J Mol Sci. 2024; 25(12).

PMID: 38928435 PMC: 11203709. DOI: 10.3390/ijms25126730.

Prognostic value of PAX8 in small cell lung cancer.

Tao F, Zhu H, Xu J, Guo Y, Wang X, Shao L Heliyon. 2024; 10(7):e28251.

PMID: 38596099 PMC: 11002052. DOI: 10.1016/j.heliyon.2024.e28251.

In Silico Functional and Structural Analysis of Non-synonymous Single Nucleotide Polymorphisms (nsSNPs) in Human Paired Box 4 Gene.

Kamal M, Islam M, Rabby M, Zahid M, Hasan M Biochem Genet. 2023; 62(4):2975-2998.

PMID: 38062275 DOI: 10.1007/s10528-023-10589-1.

References

Grote D, Souabni A, Busslinger M, Bouchard M . Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development. 2005; 133(1):53-61. DOI: 10.1242/dev.02184. View

Rodgers L, O hAinmhire E, Young A, Burdette J . Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Oncotarget. 2016; 7(22):32785-95. PMC: 5078051. DOI: 10.18632/oncotarget.9051. View

Orvis G, Behringer R . Cellular mechanisms of Müllerian duct formation in the mouse. Dev Biol. 2007; 306(2):493-504. PMC: 2730733. DOI: 10.1016/j.ydbio.2007.03.027. View

Fares B, Berger L, Bangiev-Girsh E, Kakun R, Ghannam-Shahbari D, Tabach Y . PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer. Oncogene. 2021; 40(34):5275-5285. DOI: 10.1038/s41388-021-01925-z. View

Tai T, Jennermann C, Brown K, OLIVER B, MacGinnitie M, Wilkison W . Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation. J Biol Chem. 1996; 271(47):29909-14. DOI: 10.1074/jbc.271.47.29909. View

Mark M, Rijli F, Chambon P . Homeobox genes in embryogenesis and pathogenesis. Pediatr Res. 1997; 42(4):421-9. DOI: 10.1203/00006450-199710000-00001. View

Narlis M, Grote D, Gaitan Y, Boualia S, Bouchard M . Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol. 2007; 18(4):1121-9. DOI: 10.1681/ASN.2006070739. View

Bhatlekar S, Fields J, Boman B . HOX genes and their role in the development of human cancers. J Mol Med (Berl). 2014; 92(8):811-23. DOI: 10.1007/s00109-014-1181-y. View

Dralle H, Machens A, Basa J, Fatourechi V, Franceschi S, Hay I . Follicular cell-derived thyroid cancer. Nat Rev Dis Primers. 2016; 1:15077. DOI: 10.1038/nrdp.2015.77. View

10.

Kousta E, Papathanasiou A, Skordis N . Sex determination and disorders of sex development according to the revised nomenclature and classification in 46,XX individuals. Hormones (Athens). 2010; 9(3):218-131. DOI: 10.14310/horm.2002.1272. View

11.

Perets R, Drapkin R . It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research. Cancer Res. 2015; 76(1):10-7. PMC: 4703449. DOI: 10.1158/0008-5472.CAN-15-1382. View

12.

Chi N, Epstein J . Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 2001; 18(1):41-7. DOI: 10.1016/s0168-9525(01)02594-x. View

13.

Hung N, Chen Y, Taha A, Olivecrona M, Boet R, Wiles A . Increased paired box transcription factor 8 has a survival function in glioma. BMC Cancer. 2014; 14:159. PMC: 4015841. DOI: 10.1186/1471-2407-14-159. View

14.

Balczarek K, Lai Z, Kumar S . Evolution of functional diversification of the paired box (Pax) DNA-binding domains. Mol Biol Evol. 1997; 14(8):829-42. DOI: 10.1093/oxfordjournals.molbev.a025824. View

15.

MAUCHAMP J, Mirrione A, Alquier C, Andre F . Follicle-like structure and polarized monolayer: role of the extracellular matrix on thyroid cell organization in primary culture. Biol Cell. 1998; 90(5):369-80. View

16.

Robboy S, Kurita T, Baskin L, Cunha G . New insights into human female reproductive tract development. Differentiation. 2017; 97:9-22. PMC: 5712241. DOI: 10.1016/j.diff.2017.08.002. View

17.

Lang D, Powell S, Plummer R, Young K, Ruggeri B . PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol. 2006; 73(1):1-14. DOI: 10.1016/j.bcp.2006.06.024. View

18.

Enewold L, Zhu K, Ron E, Marrogi A, Stojadinovic A, Peoples G . Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009; 18(3):784-91. PMC: 2676561. DOI: 10.1158/1055-9965.EPI-08-0960. View

19.

Cheung H, Cowley G, Weir B, Boehm J, Rusin S, Scott J . Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A. 2011; 108(30):12372-7. PMC: 3145679. DOI: 10.1073/pnas.1109363108. View

20.

Rieck S, White P, Schug J, Fox A, Smirnova O, Gao N . The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol. 2009; 23(10):1702-12. PMC: 2754894. DOI: 10.1210/me.2009-0144. View